A new solvate of epalerstat, a drug for diabetic neuropathy

2Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Epalerstat {systematic name: (5Z)-5-[(2E)-2-methyl-3-phenylprop-2-en-1-ylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidine-3-acetic acid} crystallized as an acetone monosolvate, C15H13NO3S2·C3H6O. In the epalerstat molecule, the methylpropylenediene moiety is inclined to the phenyl ring and the five-membered rhodamine ring by 21.4 (4) and 4.7 (4)°, respectively. In addition, the acetic acid moiety is found to be almost normal to the rhodamine ring, making a dihedral angle of 85.1 (2)°. In the crystal, a pair of O - H⋯O hydrogen bonds between the carboxylic acid groups of epalerstat molecules form inversion dimers with an R22(8) loop. The dimers are linked by pairs of C - H⋯O hydrogen bonds, enclosing R22(20) loops, forming chains propagating along the [101] direction. In addition, the acetone molecules are linked to the chain by a C - H⋯O hydrogen bond. Epalerstat acetone monosolvate was found to be isotypic with epalerstat tertrahydrofuran solvate [Umeda et al. (2017). Acta Cryst. E73, 941-944].

Cite

CITATION STYLE

APA

Putra, O. D., Umeda, D., Fukuzawa, K., Gunji, M., & Yonemochi, E. (2017). A new solvate of epalerstat, a drug for diabetic neuropathy. Acta Crystallographica Section E: Crystallographic Communications, 73, 1264–1267. https://doi.org/10.1107/S2056989017010751

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free